cardiac hypertrophy


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to cardiac hypertrophy: myocardial hypertrophy

hypertrophy

 [hi-per´tro-fe]
increase in volume of a tissue or organ produced entirely by enlargement of existing cells. See also hyperplasia and proliferation. adj., adj hypertro´phic.
asymmetrical septal hypertrophy
2. the term is sometimes limited to cases of hypertrophic cardiomyopathy in which the hypertrophy is localized to the interventricular septum. See also hypertrophic obstructive cardiomyopathy.
benign prostatic hypertrophy (BPH) age-associated enlargement of the prostate resulting from proliferation of glandular and stromal elements, beginning generally in the fifth decade of life; it may cause urethral compression and obstruction. Called also benign prostatic hyperplasia and nodular hyperplasia of the prostate.
cardiac hypertrophy enlargement of myocardial cells and hyperplasia of nonmuscular cardiac components due to pressure and volume overload and sometimes to neurohumoral factors.
compensatory hypertrophy that which results from an increased workload due to some physical defect, such as in an organ where one part is defective, or in one kidney when the other is absent or nonfunctional.
functional hypertrophy hypertrophy of an organ or part caused by its increased activity.
ventricular hypertrophy hypertrophy of the myocardium of a ventricle, due to chronic pressure overload; it is manifest electrocardiographically by increased QRS complex voltage, frequently accompanied by repolarization changes.

cardiac hypertrophy

an abnormal enlargement of the heart muscle, often associated with increased afterload. It frequently accompanies long-standing hypertension and congestive heart failure.

cardiac hypertrophy

Compensatory enlargement of the heart, which may be physiologic, as occurs in athletes, or pathological, due to underlying cardiac disease—e.g., congestive heart failure, valve disease, hypertension.

Types
• Pressure load hypertrophy—e.g., aortic valve stenosis; the left ventricular wall is thickened to 2 cm or more.
• Volume load hypertrophy—e.g., aortic valve regurgitation; the left ventricular cavity diameter is greatly increased; the wall is unchanged.

Determinants, left ventricular mass
Total body size, amount of regular physical exercise, blood pressure.

cardiac hypertrophy

Cardiac enlargement Compensatory enlargement of the heart, which may be pathologic, due to underlying cardiac disease–eg, CHF, valve disease, HTN, or physiologic, as in athletes. See Athlete's heart syndrome, Congestive heart failure.

cardiac hypertrophy

thickening of the myocardium, particularly the left ventricle. This may occur physiologically as a result of athletic training and is usually a uniform increase in thickness of the ventricular wall. Pathologically it may be the result of hypertension, secondary to outflow tract obstruction (e.g. aortic valve stenosis) or to congenital abnormalities. See also athlete's heart, hypertrophic obstructive cardiomyopathy (HOCM).

cardiac

1. pertaining to the heart. See also heart.
2. pertaining to the gastric cardia.

cardiac afterload
the impedance to ventricular emptying presented by aortic pressure.
cardiac area
cardiac biopsy
an uncommon clinical procedure. May be performed via thoracotomy or with a biopsy catheter introduced intravenously.
cardiac catheterization
the insertion of a catheter into a vein or artery and guiding it into the interior of the heart for purposes of measuring cardiac output, determining the oxygen content of blood in the heart chambers, and evaluating the structural components of the heart.
cardiac compensation
in cardiac disease the compensation for the inefficiency of the heart's pump action by enlisting the various reserves of the heart such as hypertrophy, enlargement, increase in rate, so as to maintain circulatory equilibrium and prevent the appearance of signs of congestive heart failure.
cardiac compression
an emergency measure to empty the ventricles of the heart in an effort to circulate the blood, and also to stimulate the heart so that it will resume its pumping action. Involves the application of pressure through the thoracic wall. More commonly used in animals than other forms of cardiac massage.
cardiac conducting cells
specialized cardiac fibers modified to conduct impulses from the A-V node via the septum to the ventricles. Called also Purkinje fibers.
cardiac conducting system
the cardiac tissue responsible for electrical conduction, made up of the sinoatrial node, the atrioventricular node, and the atrioventricular bundle and cardiac conducting fibers.
cardiac depressor nerve
a branch of the vagus nerve composed of afferent nerve fibers which arise around the base of the heart; called also aortic nerve.
cardiac dilatation
the heart volume is increased but the effective mass of cardiac muscle is not. A dilated heart has lost some of its reserve.
cardiac dullness
the area of the chest wall over which a dull sound, indicating the position of the heart, can be elicited by percussion.
cardiac failure
cardiac fibrillation
see ventricular fibrillation.
cardiac fibrosis
see cardiac cirrhosis.
cardiac flow load
the work required of the heart can be increased by a need for an increased flow rate of blood, e.g. when there is an anastomosis, congenital arteriovenous defect, portosystemic shunt.
cardiac function curves
statistical curves used in modeling the cardiovascular functions, relating e.g. venous return to cardiac output.
cardiac glands
in the cardiac region of the gastric wall; branched, tubular, coiled, mucus-secreting.
cardiac glycosides
the glycosides of Digitalis purpurea (digitoxin, gitalin and gitoxin) and digoxin (from D. lanata). Strophanthin and ouabain are glycosides found in Strophanthus spp. Other cardiac glycosides are present in the skin of toads (Bufo maritimus, B. vulgaris), but are of toxicological rather than therapeutic interest.
cardiac horse sickness
see african horse sickness.
cardiac hypertrophy
enlargement of the heart coincident with an increase in muscle mass; an indication of response to an increase in load which may or may not be associated with disease. It is an expression of cardiac compensation but some of the cardiac reserve has been lost.
cardiac impulse
see cardiac impulse. Called also apex beat.
cardiac index
cardiac output divided by the animal's body surface area in m2. The normal range for dogs is 1.8-3.5 l/m2.
left-sided cardiac enlargement
may involve either the left ventricle or atrium, or both, and can be demonstrated on radiographs and electrocardiography. Seen most commonly in mitral valvular disease in dogs.
cardiac massage
manual massage of the heart or stimulation with an electrical current through an open thoracic wall. The term is sometimes used interchangeably with cardiac compression.
cardiac mucosa
the most cranial of the gastric mucosae; secretes only mucus, except in pigs, in which the area covered by this mucosa is much larger than in the other species and bicarbonate is also secreted.
cardiac murmur
see heart murmur.
cardiac output
the volume of blood pumped per unit of time. May be calculated by oxygen consumption measurement or determined by dilution of indocyanine green or cold saline, using catheters with thermistors placed intravenously (thermodilution method). It can be estimated clinically by measuring heart rate, pulse quality or pressure, and assessment of tissue perfusion, e.g. capillary refill time.
cardiac pacing
employing cardiac pacemakers to control heart rate.
cardiac preload
ventricular end-diastolic volume.
cardiac pressure load
the stress of working against an elevated blood pressure in the arterial circuit; one of the two major groups of causes of heart disease; the other is flow load.
cardiac racing syndrome
a disease of companion birds manifested by a sudden increase in heart rate, up to 1000/min, in the period immediately after being restrained. Death occurs within a few seconds.
cardiac reserve
the reserve mechanisms in the heart to compensate for defects which could make the heart's pumping action ineffective. The reserve mechanisms include hypertrophy, enlargement, increase in heart rate and an increase in stroke volume, a result of the increase in muscle mass and the enlargement of the ventricles.
right-sided cardiac enlargement
may involve either the right ventricle or atrium. Occurs in heartworm disease in dogs.
cardiac rupture
penetration of the myocardium by a reticular foreign body in cows, or rupture of a patch of chronic fibrotic myocarditis in horses, causes cardiac tamponade and sudden death.
cardiac size
may increase as a result of hypertrophy, dilatation or a combination of the two. A common belief with some scientific support is that performance of horses in sprint races is closely related to heart size.
cardiac stroke volume
the amount of blood ejected with each systole.
cardiac thrill
see thrill.
cardiac valve fenestration
the valve surface is incomplete, creating a lattice effect; mostly congenital defects in foals.
cardiac valve hematocysts
congenital, blood-filled cysts on the atrioventricular valves considered to be of no pathogenic significance.
cardiac valve laceration
tearing of the valve tissue or attachment to myocardium may occur spontaneously or as a sequel to endocarditis; adds a significant additional flow load to the heart.
cardiac valve rupture
see cardiac valve laceration (above).
cardiac valves
heart valves formed by evaginations of the cardiac and vascular endothelium supported by connective tissue; includes atrioventricular and semilunar valves on both sides of the heart.
cardiac valvular disease
see valvular disease.
cardiac vascular shunts
includes patent foramen ovale, ventricular septal defect, tetralogy of Fallot, patent ductus arteriosus.
cardiac work
includes effective work—that needed for the onward propulsion of blood through the correct channels against arterial pressure, total work—includes all of the work performed by the heart including some involved in moving blood in the wrong direction.
References in periodicals archive ?
The main changes of the heart structure in ventricular remodeling are cardiac hypertrophy and fibrosis.
Cardiac hypertrophy, which afflicts one in 500 people, can be caused by high blood pressure or inherited through genes that control contraction of the heart.
During her internship, Abdelaziz developed new basic science skills including isolating neonatal rat ventricular cardiomyocytes and characterising them for cardiac hypertrophy.
In harmful cardiac hypertrophy, the heart muscle thickens and the size of the chambers decreases, making the heart less efficient at pumping.
Another possible mechanism of cardiac hypertrophy is that left ventricular mass appears to be more strongly related to the peripheral pulse pressure, measurements of hemodynamic pulsatile load during exercise in athletes (17) (Fig.
The main findings of the present study are that four weeks resistance training: i) increases the weight lifting ability, ii) Induces cardiac hypertrophy without any change in cardiac function statistically and iii) do not preserve the heart against IR-induced injuries as evidenced by no change in infarct size and apoptosis rate.
In an animal model, resveratrol has also been found to help prevent cardiac hypertrophy induced by high blood pressure.
Testosterone allows you to develop a big, lean body mass, allows you to push yourself much harder than the heart would like, maybe even causes endothelial dysfunction, may cause more cardiac hypertrophy, and it could in the long run be the reason why males are nine times more likely to die during exercise than females.
Moreover, exogenous administration of IGF-I independently promotes collagen synthesis by cardiac fibroblasts, leading to cardiac hypertrophy after long-term training (Horio et al.
When he is not involved with part-time media work or studying to be a medical doctor, the 22-year-old Bahraini has his eyes focused down a microscope and he waxes lyrical about the research in molecular biology into stopping cardiac hypertrophy (unwanted increase in heart size) that he is continuing at the laboratories of the University of Manitoba in Canada.
4,5) These cholesterol-independent effects include impedance or reversal of atherosclerotic plaque formation, improvements in arterial function, anti-clotting effects, anti-inflammatory effects, antioxidant effects, inhibition of smooth muscle cell proliferation during plaque formation, prevention of plaque rupture, and prevention of cardiac hypertrophy.